Skip to main content
HR 573 111th Congress House

To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.

Introduced: January 15, 2009 See on congress.gov
Health Drug safety, medical device, and laboratory regulationPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 111th Congress ended
It never became law before the 111th Congress (2009–2010) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 16, 2009
Referred to the Subcommittee on Health.
Jan 15, 2009
Referred to the House Committee on Energy and Commerce.
Jan 15, 2009
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action January 16, 2009

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 573: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.. 111th Congress. Open America. https://openamerica.io/bill/111-HR-573/
MLA
"H.R. 573: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.." 111th Congress, 2026, Open America, https://openamerica.io/bill/111-HR-573/.
Bluebook (legal)
H.R. 573, 111th Cong. (2026), https://openamerica.io/bill/111-HR-573/.
Markdown link
[H.R. 573: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.](https://openamerica.io/bill/111-HR-573/)
Report a problem